Stephen Franklin
Plus aucun poste en cours
Historique de carrière de Stephen Franklin
Anciens postes connus de Stephen Franklin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2008 | 30/04/2020 |
| Fondateur | 01/01/2008 | 30/04/2020 | |
| THERACRYF PLC | Directeur/Membre du Conseil | 02/10/2014 | 30/04/2020 |
| Directeur Général | 02/10/2014 | 30/04/2020 | |
| Fondateur | 01/01/2007 | 30/04/2020 | |
| Investor Relations Contact | - | - | |
| PROVEXIS PLC | Directeur Général | 01/09/2002 | 01/07/2007 |
| Fondateur | 01/09/2002 | 01/07/2007 | |
| ANGLE PLC | Corporate Officer/Principal | 01/04/1998 | 01/09/2002 |
| Manchester Biotech Ltd. | Corporate Officer/Principal | - | - |
Formation de Stephen Franklin
| The University of Nottingham | Masters Business Admin |
| York University | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 7 |
| Canada | 2 |
Opérationnelle
| Founder | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Services | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PROVEXIS PLC | Health Technology |
| ANGLE PLC | Distribution Services |
| THERACRYF PLC | Health Services |
| Entreprise privées | 2 |
|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
| Manchester Biotech Ltd. |
- Bourse
- Insiders
- Stephen Franklin
- Expérience
